Summary of Purpose
The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery. Trial Stopped: study stopped because patient access became extremely limited for the initial data entry point.Read More →
The following dates are available for this trial. Trial information last updated on 9 March 2018.
|1 Sep 2012||9 Oct 2012||1 Dec 2017||1 Feb 2018||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample